HighPoint Advisor Group’s Collegium Pharmaceutical COLL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-5,660
Closed -$262K 730
2025
Q4
$262K Sell
5,660
-1,050
-16% -$43.9K 0.01% 910
2025
Q3
$235K Buy
+6,710
New +$233K 0.01% 610
2025
Q2
Sell
-7,790
Closed -$215K 681
2025
Q1
$215K Sell
7,790
-1,650
-17% -$50.4K 0.01% 605
2024
Q4
$298K Sell
9,440
-3,992
-30% -$132K 0.02% 512
2024
Q3
$449K Hold
13,432
0.03% 380
2024
Q2
$518K Sell
13,432
-3,257
-20% -$113K 0.03% 341
2024
Q1
$537K Buy
16,689
+4
+0% +$140 0.04% 333
2023
Q4
$670K Buy
+16,685
New +$418K 0.05% 287
2022
Q2
$422K Buy
+21,906
New +$369K 0.05% 318
2021
Q3
$594K Sell
30,077
-550
-2% -$11.9K 0.06% 276
2021
Q2
$724K Buy
30,627
+118
+0.4% +$2.73K 0.07% 230
2021
Q1
$712K Sell
30,509
-7,806
-20% -$185K 0.08% 200
2020
Q4
$997K Buy
+38,315
New +$748K 0.12% 144

Other funds holding COLL